Hypha Labs (FUNI) EBITDA Margin (2011 - 2024)
Hypha Labs' (FUNI) quarterly EBITDA Margin came in at 67.84% in Q1 2024, up 2826.0% YoY from 2.32% in Q2 2023, and up 987.54% on a QoQ basis from 7.64% in Q4 2023.
Hypha Labs (FUNI) EBITDA Margin (2011 - 2024) Analysis & Trends
Hypha Labs (FUNI) has 14 years of EBITDA Margin data on file, last reported at 67.84% in Q1 2024.
- Quarterly EBITDA Margin rose 2826.0% year-over-year to 67.84% in Q1 2024, while the trailing twelve-month figure through Sep 2024 was 25.23% (down 1092.0% YoY) and the FY2024 annual result came in at 60.22%, up 1235.0% from the prior year.
- EBITDA Margin improved to 67.84% in Q1 2024, from 7.64% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 67.84% in Q1 2024 to a low of 151.57% in Q3 2020.
- A 5-year average of 25.65% and a median of 23.18% in 2022 frame the typical range for EBITDA Margin.
- Annual changes were most pronounced in 2020 — EBITDA Margin plunged 8649 bps — and 2021, when it surged 10527 bps.
- Tracing FUNI's EBITDA Margin over 5 years: stood at 69.6% in 2020, then jumped by 55 bps to 31.1% in 2021, then surged by 62 bps to 11.86% in 2022, then soared by 36 bps to 7.64% in 2023, then jumped by 988 bps to 67.84% in 2024.
- The last three EBITDA Margin figures came in at 67.84% (Q1 2024), 7.64% (Q4 2023), and 55.45% (Q3 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.40 Bn | 209.33 Bn | 8.34 Bn | 17.40% |
| 2 | Danaher | 139.94 Bn | 135.59 Bn | 3.61 Bn | 17.99% |
| 3 | Idexx Laboratories | 46.03 Bn | 45.83 Bn | 779.09 Mn | 34.98% |
| 4 | Agilent Technologies | 39.69 Bn | 37.88 Bn | 990.00 Mn | 21.74% |
| 5 | Iqvia Holdings | 39.32 Bn | 37.24 Bn | 1.44 Bn | 11.58% |
| 6 | Natera | 38.47 Bn | 37.37 Bn | 696.04 Mn | -13.42% |
| 7 | Illumina | 29.98 Bn | 28.82 Bn | 770.00 Mn | 21.14% |
| 8 | Mettler Toledo International | 28.57 Bn | 28.52 Bn | 650.22 Mn | 31.97% |
| 9 | Quest Diagnostics | 26.21 Bn | 25.58 Bn | 1.03 Bn | 15.08% |
| 10 | Hypha Labs | 2.26 Mn | 2.18 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 67.84% |
| Dec 31, 2023 | -7.64% |
| Sep 30, 2023 | 55.45% |
| Jun 30, 2023 | 51.27% |
| Mar 31, 2023 | 39.58% |
| Dec 31, 2022 | -11.86% |
| Sep 30, 2022 | -43.85% |
| Jun 30, 2022 | -23.18% |
| Mar 31, 2022 | -51.79% |
| Dec 31, 2021 | -31.10% |
| Sep 30, 2021 | -46.31% |
| Jun 30, 2021 | -19.12% |
| Mar 31, 2021 | 0.41% |
| Dec 31, 2020 | -69.60% |
| Sep 30, 2020 | -151.57% |
| Jun 30, 2020 | -115.88% |
| Mar 31, 2020 | -78.71% |
| Dec 31, 2019 | -26.19% |
| Sep 30, 2019 | -65.09% |
| Jun 30, 2019 | -75.23% |